IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Clinical trial NCT01314118 · COMPLETED
Trial details
- NCT number
- NCT01314118
- Sponsor
- Janssen Biotech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-04
- Primary completion
- 2013-12-24
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.